Latest Pharmaceutical Safety News

Page 1 of 1

Noxopharm Advances HERACLES Trial, Clears Third SOF-SKN™ Dose Safely

Noxopharm has successfully completed the third dosing phase of its HERACLES trial for SOF-SKN™, confirming safety and moving forward to the highest dose cohort in this pioneering autoimmune drug study.

Ada Torres

25 Aug 2025

Top